Drawing for GAS-EFX

USPTO serial 75038198

GAS-EFX

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SNAPP, TINA LOUISE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GAS-EFX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Martin Korn

MARTIN KORN ROSS, CLAPP, KORN & MONTGOMERY LLP14651 DALLAS PKWY STE 102DALLAS, TX 75240-7477UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparation for the treatment of gastrointestinal disordersABANDONEDFeb 8, 1996

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 14, 1996ABN5ABANDONMENT - AFTER PUBLICATION—
Oct 7, 1996ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 3, 1996PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 1996NPUBNOTICE OF PUBLICATION—
Jul 5, 1996CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 5, 1996IUAAUSE AMENDMENT ACCEPTED—
Jun 19, 1996CNEAEXAMINER'S AMENDMENT MAILED—
Jun 13, 1996DOCKASSIGNED TO EXAMINER—
Mar 29, 1996AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Feb 26, 1996IUAFUSE AMENDMENT FILED—

Frequently asked questions

Related guidance